Welcome to Take 10, where the topics are focused, the conversations are quick, and the insights are real. Each month, we bring you thoughtful exchanges with patient advocates, researchers, innovators, industry experts, care specialists, and more – all to illuminate the most significant developments in oncology and the people who are redefining life with cancer.
All content for Take 10 is the property of Johnson & Johnson and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Take 10, where the topics are focused, the conversations are quick, and the insights are real. Each month, we bring you thoughtful exchanges with patient advocates, researchers, innovators, industry experts, care specialists, and more – all to illuminate the most significant developments in oncology and the people who are redefining life with cancer.
Episode 4 – Chumi Khurna, Vice President, U.S. Marketing and Sales, Solid Tumor and June Lanoue, Vice President., U.S. Marketing, Hematology
Take 10
24 minutes 23 seconds
1 year ago
Episode 4 – Chumi Khurna, Vice President, U.S. Marketing and Sales, Solid Tumor and June Lanoue, Vice President., U.S. Marketing, Hematology
September represents both Prostate Cancer Awareness Month and Blood Cancer Awareness Month, two areas where J&J Oncology is highly committed to reimaging care so that patients can redefine living. In this "Special Edition" Take 20 episode, Tyrone speaks with his J&J colleagues, Chumi Khurana, Vice President of U.S. Marketing and Sales, Solid Tumor, and June Lanoue, Vice President of U.S. Marketing and Sales, Hematology. The team discusses the importance of going beyond traditional “awareness” and while exploring the progress being made as an industry to address these conditions and the treatment paradigms, as well as efforts to overcome health inequities when it comes to diagnosis and treatment.
Take 10
Welcome to Take 10, where the topics are focused, the conversations are quick, and the insights are real. Each month, we bring you thoughtful exchanges with patient advocates, researchers, innovators, industry experts, care specialists, and more – all to illuminate the most significant developments in oncology and the people who are redefining life with cancer.
